AstraZeneca, the British-Swedish pharmaceutical company headed to market with its COVID-19 vaccine, said Tuesday that its published results went exactly as planned, despite questions from the National Institute of Health.
AstraZeneca, the British-Swedish pharmaceutical company headed to market with its COVID-19 vaccine, said Tuesday that its published results went exactly as planned, despite questions from the National Institute of Health.